Oregon Health Authority Public Comments March 2026
MicroTransponder Seeks Medicaid Coverage for Implantable VNS Device
Trusted by teams at
Description
MicroTransponder, Inc. advocated for Medicaid coverage of their implantable VNS device for post-stroke upper extremity rehabilitation in public comments to the Health Evidence Review Commission. The submission focused on supporting evidence for improved outcomes in qualifying patients.
Contract Details
Vendor
MICROTRANSPONDER INC
Agency
Oregon HA | Health Evidence Review Commission, OR
Contract Type
EQUIPMENT
Document Date
March 16, 2026
More from Oregon HA | Health Evidence Review Commission
Oregon HA Health Evidence Review Commission Report Acellular Scaffold Implant March 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.